Scopus WoS Q2
SCI-Expanded Hakemli
Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model
Molecular Immunology · 2021 · Cilt 133
Mouse model
Brusellosis
Marker Vaccine
Omp19